FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

475211000001103: Selegiline 10mg tablets (Kent Pharma (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1866761000001118 Selegiline 10mg tablets (Kent Pharma (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1866771000001111 Selegiline 10mg tablets (Kent Pharma (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Selegiline 10mg tablets (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Selegiline 10mg tablets (Kent Pharma (UK) Ltd) Is a Product containing precisely selegiline hydrochloride 10 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Selegiline 10mg tablets (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Selegiline 10mg tablets (Kent Pharma (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Selegiline 10mg tablets (Kent Pharma (UK) Ltd) Has active ingredient Selegiline hydrochloride false Inferred relationship Existential restriction modifier
Selegiline 10mg tablets (Kent Pharma (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Selegiline 10mg tablets (Kent Pharma (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Selegiline 10mg tablets (Kent Pharma (UK) Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Selegiline 10mg tablets (Kent Pharma (UK) Ltd) Has specific active ingredient Selegiline hydrochloride true Inferred relationship Existential restriction modifier
Selegiline 10mg tablets (Kent Pharma (UK) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Selegiline 10mg tablets (Kent Pharma (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Selegiline 10mg tablets (Kent Pharma (UK) Ltd) 30 tablet Is pack of False Selegiline 10mg tablets (Kent Pharma (UK) Ltd) Inferred relationship Existential restriction modifier
Selegiline 10mg tablets (Kent Pharma (UK) Ltd) 30 tablet Has AMP True Selegiline 10mg tablets (Kent Pharma (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start